Short-term effect of different teaching methods on nasopharyngeal carcinoma for general practitioners in Jakarta, Indonesia

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Wildeman, Maarten A ^a   Fles, Renske ^a   Adham, Marlinda ^b   Mayangsari, Ika D ^b   Luirink, Ilse ^a   Sandberg, Mara ^a   Vincent, Andrew D ^a   Fardizza, Faiziah ^b   Musa, Zanil ^b   Armiyanto, ^b   Middeldorp, Jaap M ^c   Gerritsen, Geerten ^a   Suwanto, Ronny ^b   Tan, I Bing ^a,d,e  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b CIPTO MANGUNKUSUMO HOSPITAL   (Indonesia)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d GADJAH MADA UNIVERSITY   (Indonesia)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; GENERAL PRACTITIONER; HUMAN; INDONESIA; MEDICAL EDUCATION; NASOPHARYNX CARCINOMA; PRIMARY HEALTH CARE; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE; RISK FACTOR; SYMPTOM; TEACHING; UNIVERSITY HOSPITAL; WORK EXPERIENCE; ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; EDUCATION; INCIDENCE; INFANT; METHODOLOGY; NASOPHARYNX TUMOR; NEWBORN; PRESCHOOL CHILD; RECALL; STATISTICS; TIME;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; EDUCATION, MEDICAL, CONTINUING; GENERAL PRACTITIONERS; HUMANS; INCIDENCE; INDONESIA; INFANT; INFANT, NEWBORN; MENTAL RECALL; NASOPHARYNGEAL NEOPLASMS; PRIMARY HEALTH CARE; QUESTIONNAIRES; RISK FACTORS; TIME FACTORS; YOUNG ADULT;

EID: 84858203076     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032756     Document Type: Article

References (43)

1. Plianbangchang S, (2007) WHO Country Cooperation Strategy 2007-2011 Indonesia.
2. Drager N, Vieira C, (2002) Trade in health services: global, regional, and country perspectives.
3. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer 127: 2893-2917.
4. Yu MC, Yuan JM, (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429.
5. Devi BC, Pisani P, Tang TS, Parkin DM, (2004) High incidence of nasopharyngeal carcinoma in native people of Sarawak, Borneo Island. Cancer Epidemiol Biomarkers Prev 13: 482-486.
6. Wei WI, Sham JS, (2005) Nasopharyngeal carcinoma. Lancet 365: 2041-2054.
7. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, et al. (1970) EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature 228: 1056-1058.
8. Poirier S, Hubert A, D-The G, Ohshima H, Bourgade MC, et al. (1987) Occurrence of volatile nitrosamines in food samples collected in three high-risk areas for nasopharyngeal carcinoma. IARC Sci Publ 415-419.
9. Guo X, Johnson RC, Deng H, Liao J, Guan L, et al. (2009) Evaluation of nonviral risk factors for nasopharyngeal carcinoma in a high-risk population of Southern China. Int J Cancer 124: 2942-2947.
10. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, et al. (1998) Nasopharyngeal carcinoma in Malaysian Chinese: salted fish and other dietary exposures. Int J Cancer 77: 228-235.
11. Armstrong RW, Imrey PB, Lye MS, Armstrong MJ, Yu MC, et al. (2000) Nasopharyngeal carcinoma in Malaysian Chinese: occupational exposures to particles, formaldehyde and heat. Int J Epidemiol 29: 991-998.
12. Chang ET, Adami HO, (2006) The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1765-1777.
13. Parkin DM, Bray F, Ferlay J, Pisani P, (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108.
14. Ozyar E, Atahan IL, Akyol FH, Gurkaynak M, Zorlu AF, (1994) Cranial nerve involvement in nasopharyngeal carcinoma: its prognostic role and response to radiotherapy. Radiation medicine 12: 65-68.
15. Lee AW, Foo W, Law SC, Poon YF, Sze WM, et al. (1997) Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J 3: 355-361.
16. Zhang L, Zhao C, Ghimire B, Hong MH, Liu Q, et al. (2010) The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trials. BMC Cancer 10: 558.
17. Lee AW, Sze WM, Au JS, Leung SF, Leung TW, et al. (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys 61: 1107-1116.
18. Lee AW, Poon YF, Foo W, Law SC, Cheung FK, et al. (1992) Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23: 261-270.
19. Fles R, Wildeman MA, Sulistiono B, Haryana SM, Tan IB, (2010) Knowledge of general practitioners about nasopharyngeal cancer at the Puskesmas in Yogyakarta, Indonesia. BMC Med Educ 10: 81.
20. Devi BC, Tang TS, Corbex M, (2007) Reducing by half the percentage of late-stage presentation for breast and cervix cancer over 4 years: a pilot study of clinical downstaging in Sarawak, Malaysia. Ann Oncol 18: 1172-1176.
21. Prasad U, Pua KC, (2000) Nasopharyngeal carcinoma: a delay in diagnosis. Med J Malaysia 55: 230-235.
22. Alho OP, Teppo H, Mantyselka P, Kantola S, (2006) Head and neck cancer in primary care: presenting symptoms and the effect of delayed diagnosis of cancer cases. CMAJ 174: 779-784.
23. Koivunen P, Rantala N, Hyrynkangas K, Jokinen K, Alho OP, (2001) The impact of patient and professional diagnostic delays on survival in pharyngeal cancer. Cancer 92: 2885-2891.
24. Teppo H, Koivunen P, Hyrynkangas K, Alho OP, (2003) Diagnostic delays in laryngeal carcinoma: professional diagnostic delay is a strong independent predictor of survival. Head Neck 25: 389-394.
25. Wildeman MA, Zandbergen J, Vincent A, Herdini C, Middeldorp JM, et al. (2011) Can an online clinical data management service help in improving data collection and data quality in a developing country setting? Trials 12: 190.
26. Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, et al. (1986) Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma. J Infect 12: 127-131.
27. Chen JY, Chen CJ, Liu MY, Cho SM, Hsu MM, et al. (1987) Antibodies to Epstein-Barr virus-specific DNase in patients with nasopharyngeal carcinoma and control groups. J Med Virol 23: 11-21.
28. Ji MF, Wang DK, Yu YL, Guo YQ, Liang JS, et al. (2007) Sustained elevation of Epstein-Barr virus antibody levels preceding clinical onset of nasopharyngeal carcinoma. Br J Cancer 96: 623-630.
29. Tamada A, Makimoto K, Yamabe H, Imai J, Hinuma Y, et al. (1984) Titers of Epstein-Barr virus-related antibodies in nasopharyngeal carcinoma in Japan. Cancer 53: 430-440.
30. de Vathaire F, Sancho-Garnier H, de-The H, Pieddeloup C, Schwaab G, et al. (1988) Prognostic value of EBV markers in the clinical management of nasopharyngeal carcinoma (NPC): a multicenter follow-up study. Int J Cancer 42: 176-181.
31. Fachiroh J, Schouten T, Hariwiyanto B, Paramita DK, Harijadi A, et al. (2004) Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: a comparison of Indonesian, Chinese, and European subjects. J Infect Dis 190: 53-62.
32. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, et al. (2006) Single-assay combination of Epstein-Barr Virus (EBV) E. J Clin Microbiol 44: 1459-1467.
33. Paramita DK, Fachiroh J, Artama WT, van Benthem E, Haryana SM, et al. (2007) Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma. J Med Virol 79: 1710-1721.
34. Fachiroh J, Prasetyanti PR, Paramita DK, Prasetyawati AT, Anggrahini DW, et al. (2008) Dried-blood sampling for epstein-barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening. J Clin Microbiol 46: 1374-1380.
35. Paramita DK, Fachiroh J, Haryana SM, Middeldorp JM, (2009) Two-step Epstein-Barr virus immunoglobulin A enzyme-linked immunosorbent assay system for serological screening and confirmation of nasopharyngeal carcinoma. Clin Vaccine Immunol 16: 706-711.
36. Lin JC, Wang WY, Chen KY, Wei YH, Liang WM, et al. (2004) Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 350: 2461-2470.
37. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Fachiroh J, et al. (2005) Diagnostic value of measuring Epstein-Barr virus (EBV) DNA load and carcinoma-specific viral mRNA in relation to anti-EBV immunoglobulin A (IgA) and IgG antibody levels in blood of nasopharyngeal carcinoma patients from Indonesia. J Clin Microbiol 43: 3066-3073.
38. Stevens SJ, Verkuijlen SA, Hariwiyanto B, Harijadi, Paramita DK, et al. (2006) Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA. Int J Cancer 119: 608-614.
39. Tune CE, Liavaag PG, Freeman JL, van den Brekel MW, Shpitzer T, et al. (1999) Nasopharyngeal brush biopsies and detection of nasopharyngeal cancer in a high-risk population. J Natl Cancer Inst 91: 796-800.
40. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, et al. (2002) Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 8: 2612-2619.
41. Ji MF, Yu YL, Cheng WM, Zong YS, Ng PS, et al. (2011) Detection of Stage I nasopharyngeal carcinoma by serologic screening and clinical examination. Chin J Cancer 30: 120-123.
42. Ali TS, Baig S, (2006) Evaluation of a cancer awareness campaign: experience with a selected population in Karachi. Asian Pac J Cancer Prev 7: 391-395.
43. Bhurgri H, Gowani SA, Itrat A, Samani S, Zuberi A, et al. (2008) Awareness of cancer risk factors among patients and attendants presenting to a tertiary care hospital in Karachi, Pakistan. J Pak Med Assoc 58: 584-588.